Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. - sprookjes - yvandenbroek - TriplyDB

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

http://www.wikidata.org/entity/Q34010116

about

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management Acute thyroid eye disease (TED): principles of medical and surgical management Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy.The eye and thyroid disease.Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells.Effect of radiotherapy on moderate and severe thyroid associated ophthalmopathy: a double blind and self-controlled study.Proposal of success criteria for strabismus surgery in patients with Graves' orbitopathy based on a systematic literature review.Orbital decompression for Graves' orbitopathy in England Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Observation of Corneal Langerhans Cells by In Vivo Confocal Microscopy in Thyroid-Associated Ophthalmopathy.Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt.Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency.Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy.Guidance on That Damned Elusive Orbitopathy of Graves' Disease.The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy Corneal biomechanical changes and intraocular pressure in patients with thyroid orbitopathy Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.Update on advanced imaging options for thyroid-associated orbitopathy.Severe eyelid oedema in Graves' ophthalmopathy.Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy A 2015 Italian Survey of Clinical Practice Patterns in the Management of Graves' Disease: Comparison with European and North American Surveys Comparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective Trial Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy The association of carotid cavernous fistula with Graves' ophthalmopathy.Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves' Disease Previously Treated with Antithyroid Drugs.Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy

P2860

Q26782424-C498B1FF-D369-4D7A-94E3-1AEF032EFA5F Q26827429-8C07330C-1E9E-425A-8AC1-CE07E559E019 Q27005680-A5FA5830-3ECB-4655-8789-06DA2F961AEF Q30413598-40413AC5-6B0E-411D-A106-1C472C861F80 Q30883875-0B0F72BE-AB6B-4334-9962-3FE8B6878855 Q31047067-26093DB1-D6EA-4A38-88EE-6113C1C474F9 Q33348029-6533D00E-4743-4F65-9CE6-9E9598B3FCE4 Q33802192-8B7BE17F-6C79-4371-9758-CDD6451535D4 Q33827155-E2A5290C-844C-4EE9-9362-5719DBB8DCFC Q33876359-F0298C44-56BC-40F6-8E1F-C4968586298D Q34014090-D4030C55-2C34-4BB8-8CAA-473FA2EE5D4D Q34369480-C7A1CEB2-6BCB-4CC6-8FEC-3FCF307D8D26 Q34525298-2287C17E-B5FE-498E-9674-D49AD600C0FA Q35448029-E089420F-5D0C-4713-A44F-8AD2EA71E89F Q35479930-3BF1734F-36C8-4315-A895-78DD52357D63 Q35602629-32F26735-5917-48C9-867D-B7EEB66D6E5A Q35820372-7233346B-D2EC-42D4-BB21-BDEC60748029 Q35843262-5C5E8A43-923C-4C87-9660-EC1940EE3ECF Q35843863-6B7C46EE-43AF-4C5C-9B3D-07E7DF41A882 Q35886634-2017F058-6010-46B7-AF43-19A79E777F53 Q36069781-C70B52ED-07EC-497B-BA09-12EC5F5DEDBD Q36349128-B926E4B3-4D99-4FB0-830D-467E7DD1B599 Q36437367-C447F206-2B1D-4F29-81B2-A7259ADAE1A6 Q36472663-7C7D6BA5-679D-40E4-9FF9-9E1108DB03F1 Q36478242-45248D8A-AED1-4567-A7CD-687A5832B51D Q36811275-78EBAF3F-29C5-4FA1-83E7-667B5C8B0BD9 Q36811289-55216925-C92E-4C60-A57A-292E7187389E Q36832942-7ACD3041-E973-46A3-ACEE-5A80FD0F67D1 Q36833918-37DC3E98-01E2-49C8-A606-F5D413768D8D Q37054144-17ED5521-E4E5-408F-86F4-6C2DB5FE2D50 Q37060099-A43B0DB1-3F78-4DF2-A606-9F7051E1D078 Q37077273-ACE38F73-7CD3-4AE6-87FB-BEC2984484A7 Q37087157-DB6E1E9C-1B8F-48E2-8E50-56A48ECD13DE Q37104648-76A3A7F9-059C-4B7D-8CAC-8FD03E3EA726 Q37104821-909381F9-0BCC-4E76-BA19-4523D6B49E40 Q37104833-3B79DF8E-98E9-42A0-95B9-C5EEC33AE33B Q37106711-BC121ABE-0352-4259-9497-9A35D466CB9E Q37137237-3D26EF50-7A9F-4B48-9D6F-C0B85CDBAC6C Q37290885-0A3D8374-25C1-4E32-B542-501F5CDDC15D Q37370486-33CABC0F-A971-4418-B5C0-15A7D69BB6DD

P2860

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

http://www.wikidata.org/entity/Q34010116

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@ast

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@en

Consensus statement of the European Group on Graves' orbitopathy

@nl

type

label

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@ast

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@en

Consensus statement of the European Group on Graves' orbitopathy

@nl

prefLabel

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@ast

Consensus statement of the Eur ...... (EUGOGO) on management of GO.

@en

Consensus statement of the European Group on Graves' orbitopathy

@nl

P1433

Q34010116-A8268170-5725-4B4F-89A9-BC81A7BDBCA2

P1476

Q34010116-2C25BDD5-7F4B-4BFF-9CEE-D4E8E04D9BB4

P2093

Q34010116-07C805EF-D1E6-451B-94D1-52984D5952BA

Q34010116-0D3237CF-A8F4-4351-AFCF-BC5CD9118B6B

Q34010116-1A1875D1-E4B1-47C5-A274-CDDA41860757

Q34010116-31B729ED-9E6E-42DF-88B8-3957ECD643B9

Q34010116-4393DE20-9F5F-480D-ACF2-FF10387BA0D9

Q34010116-45FF2EA0-6702-4946-8205-5F13D818F3AB

Q34010116-6002812A-CD1F-4E10-A6DE-1B58B4550CE4

Q34010116-62623E8D-FBDA-4B72-91D7-57370B846BBA

Q34010116-693C2E22-50B2-45D8-92C1-1B42F265658A

Q34010116-809FC84A-C8A0-4CA7-BB6F-C1B28957F251

P304

Q34010116-9E1F576B-1C86-4A26-9181-3D48D803843B

P31

Q34010116-3CE09742-337E-40B8-AD04-FD76028454C6

P356

Q34010116-85AD6BBC-8722-41F0-9210-51313A075FDA

P433

Q34010116-A455A973-558E-4C70-BD4C-DB361FA7D70B

P478

Q34010116-E3C7267F-E061-4C49-9C18-5F7AAF80B05A

P50

Q34010116-491429B2-44D6-42D7-AAAC-14CC7DB80141

Q34010116-51B91210-BF8E-46DB-A923-D0F02CE0C122

Q34010116-83807643-37A2-479B-B387-F86164496670

Q34010116-9AA4F8D6-9F23-4457-BBE0-184DEE94E068

Q34010116-DB000355-3F5F-4C5C-9EA1-FFD866456AA7

Q34010116-DCA9E98E-D4D4-45E3-A90C-95EAC27338B6

Q34010116-FAD954AE-3570-48BE-9394-28EA5DCE3385

P577

Q34010116-DEFC852C-43E3-43AE-9B23-C934D3958C57

P5875

Q34010116-DC02847D-369F-4211-8291-3599F9C82373

P698

Q34010116-17DBE65C-0075-4915-A5C8-A4D55FF2AA72

P356

P1433

European Journal of Endocrinology

P1476

Consensus statement of the Eur ...... y (EUGOGO) on management of GO

@en

P2093

Aldo Pinchera

http://www.w3.org/2001/XMLSchema#string

Alison Dickinson

http://www.w3.org/2001/XMLSchema#string

Anja Eckstein

http://www.w3.org/2001/XMLSchema#string

Antonella Boschi

http://www.w3.org/2001/XMLSchema#string

Carol M Lane

http://www.w3.org/2001/XMLSchema#string

Chantal Daumerie

http://www.w3.org/2001/XMLSchema#string

Christopher Neoh

http://www.w3.org/2001/XMLSchema#string

Claudio Marcocci

http://www.w3.org/2001/XMLSchema#string

European Group on Graves' Orbitopathy (EUGOGO)

http://www.w3.org/2001/XMLSchema#string

Georg von Arx

http://www.w3.org/2001/XMLSchema#string

P304

273-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/EJE-07-0666

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158

http://www.w3.org/2001/XMLSchema#string

P50

Kostas G Boboridis

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5553750

http://www.w3.org/2001/XMLSchema#string

P698

18299459

http://www.w3.org/2001/XMLSchema#string